Posts tagged Mark Novotny
Spine Stabilization Technologies Chooses bioaccess™ for the Commercial Launch of its CE Mark-Approved PerQdisc™ Nucleus Replacement System in Latin America
Spine Stabilization Technologies Chooses bioaccess™ for the Commercial Launch of its CE Mark-Approved PerQdisc™ Nucleus Replacement System in Latin America

Spine Stabilization Technologies, LLC (SST), a Texas company developing a spine disc nucleus replacement technology designed to replace the physical space of the nucleus, has decided to engage bioaccess™ as its CRO in Colombia to expand its clinical research network of sites and augment the clinical data of its innovative and less invasive treatment: The PerQdisc™ Nucleus Replacement System.. bioaccess™ will help SST select at least two clinical research sites and obtain institutional review board (IRB)/ethics committee and regulatory approval at Colombia's regulatory agency (INVIMA).

Read More
Clinical Trials, Market AccessJulio G. Martinez-ClarkSpine Stabilization Technologies, SST, Mark Novotny, Degenerative disc disease, low back pain, PerQdisc™ Nucleus Replacement SystemComment